Lexicon PharmaceuticalsLXRX
那斯達克 · USD
1.51
+0.20
(+15.27%)
盤中 01/22 01:14 (UTC+8)
01/22 01:14 (UTC+8)
Lexicon PharmaceuticalsLXRX
1.51
+0.20
(+15.27%)
財務數據
損益表
- 0.00
- 0.00
- 0.01
- 0.01
- 0.02
- 0.02
- 0.27
- 0.01
- 0.29
- 0.14
- 1216.67
- -48.73
- 333.33
- 60.97
- 45.75
- 6.25
- 1417.37
- -95.25
- 2187.32
- -50.87
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 14,182 | 28,866 | 1,262 | 26,554 | 1,750 | 1,647 | 1,130 | 702 | 162 | 316 |
營業成本 | 10 | 33 | 30 | 348 | 71 | 166 | 31 | 70 | 7 | 8 |
營業毛利 | 14,172 | 28,833 | 1,232 | 26,206 | 1,679 | 1,481 | 1,099 | 632 | 155 | 308 |
營業費用 | 26,360 | 25,097 | 26,911 | 58,943 | - | - | 46,432 | 47,369 | 49,786 | 44,548 |
研發費用 | 18,756 | 15,747 | 15,303 | 26,685 | 25,780 | 17,643 | 14,372 | 14,762 | 17,558 | 14,541 |
推銷及管理費用 | 7,604 | 9,350 | 11,608 | 32,258 | 39,592 | 39,192 | 32,060 | 32,607 | 32,228 | 30,007 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -12,188 | 3,736 | -25,679 | -32,737 | -63,693 | -55,354 | -45,333 | -46,737 | -49,631 | -44,240 |
其他收入及費用 | 1,575 | 1,834 | 2,219 | 2,829 | 3,444 | 4,136 | 1,884 | 2,402 | 3,005 | 1,296 |
利息費用 | 2,155 | 2,318 | 1,835 | 3,858 | 4,562 | 2,211 | 4,948 | 5,421 | 3,899 | 1,960 |
稅前純益 | -12,768 | 3,252 | -25,295 | -33,766 | -64,811 | -53,429 | -48,397 | -49,756 | -50,525 | -44,904 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -12,768 | 3,252 | -25,295 | -33,766 | -64,811 | -53,429 | -48,397 | -49,756 | -50,525 | -44,904 |
基本每股稅後盈餘(元) | -0.04 | 0.01 | -0.07 | -0.09 | -0.18 | -0.17 | -0.20 | -0.20 | -0.21 | -0.22 |
稀釋每股稅後盈餘(元) | -0.04 | 0.01 | -0.07 | -0.09 | -0.17 | -0.17 | -0.20 | -0.20 | -0.21 | -0.22 |
基本平均股數(千股) | 363399.00 | 363294.00 | 362073.00 | 361492.00 | 361492.00 | 310836.00 | 245390.00 | 244925.00 | 244925.00 | 204783.00 |
稀釋平均股數(千股) | 363399.00 | 363570.00 | 362073.00 | 361492.00 | 361492.00 | 310836.00 | 245390.00 | 244925.00 | 244925.00 | 204783.00 |
還原基本每股稅後盈餘(元) | -0.04 | 0.01 | -0.07 | -0.09 | -0.18 | -0.17 | -0.20 | -0.20 | -0.21 | -0.22 |
還原稀釋每股稅後盈餘(元) | -0.04 | 0.01 | -0.07 | -0.09 | -0.17 | -0.17 | -0.20 | -0.20 | -0.21 | -0.22 |
還原基本平均股數(千股) | 363,399 | 363,294 | 362,073 | 361,492 | 361,492 | 310,836 | 245,390 | 244,925 | 244,925 | 204,783 |
還原稀釋平均股數(千股) | 363,399 | 363,570 | 362,073 | 361,492 | 361,492 | 310,836 | 245,390 | 244,925 | 244,925 | 204,783 |
EBITDA(千元) | -10,792 | 4,934 | -24,209 | -31,269 | -67,139 | -49,155 | -42,788 | -39,957 | -45,857 | -42,527 |